Table 1.

Engraftment of Purified Allogeneic CD34+ Lymphocyte-Depleted Marrow Cells

AnimalCD34+/kgDays After TransplantSurvival (yr)
(×10−6)WBC*ANC† >500PLTS‡ >20,000% Donorρ on d 28
>500>1,000
A89164 1.8 20 24 28 23 90%  5  
A89163 2.1 17 20 22 28 50% >6.0 
A91382 1.9 14 17 17 14 80% >4.9 
AnimalCD34+/kgDays After TransplantSurvival (yr)
(×10−6)WBC*ANC† >500PLTS‡ >20,000% Donorρ on d 28
>500>1,000
A89164 1.8 20 24 28 23 90%  5  
A89163 2.1 17 20 22 28 50% >6.0 
A91382 1.9 14 17 17 14 80% >4.9 

The purified allogeneic CD34+ marrow cells devoid of detectable mature and immature lymphocytes and myeloid cells were greater than 95%, greater than 97%, and greater than 98% CD34+ at the time of transplantation for animals A89164, A89163, and A91382, respectively.

*

Day after which total white blood cell count was maintained above 500/μL and 1,000/μL.

Day after which absolute neutrophil count was maintained above 500/μL.

Day after which platelet count was maintained above 20,000/μl without transfusion.

ρ Karyotyping was performed on bone marrow cells from each animal on day +28. For A89164, 18 of 20 metaphases were female (donor); for A89163, 8 or 16 metaphases were male (donor); and for A91382, 16 of 20 metaphases were male (donor).

Close Modal

or Create an Account

Close Modal
Close Modal